Collaborative Connected Health (CCH) for PCORI
NCT02358135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2019-08-28
Summary
The investigators propose to evaluate whether an innovative collaborative connected health (CCH) model increases access to specialists and improves patient outcomes. CCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously to maximize effectiveness in a real-world setting. CCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists. The specific aims of the proposal are to (1) determine whether the CCH model results in equivalent improvements in psoriasis disease severity compared to in-person care, (2) determine whether the CCH model results in equivalent improvements in quality of life and mental health compared to in-person care, and (3) assess whether the CCH model provides better access to care than in-person care.
Conditions
Interventions
- OTHER
-
Collaborative Connected health, (CCH)
CCH is an asynchronous, secure online platform where patients can upload images of psoriasis lesions and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
- OTHER
-
Control
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or UV therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek psoriasis care from PCPs or dermatologists, just as they would in the real world.
Sponsors & Collaborators
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
University of Southern California
lead OTHER
Principal Investigators
-
April Armstrong, MD MPH · University of Southern California
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-02
- Primary Completion
- 2017-08-20
- Completion
- 2017-08-20
Countries
- United States
Study Locations
More Related Trials
-
A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis
NCT03971825 ·Status: TERMINATED ·Phase: PHASE1
-
Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current
NCT01765985 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
NCT06357221 ·Status: COMPLETED ·Phase: PHASE4
-
A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis
NCT01465061 ·Status: COMPLETED
-
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265 ·Status: RECRUITING
-
Clinical Study to Investigate Psorax35 Supplementation in Patients With Psoriasis
NCT03359577 ·Status: COMPLETED ·Phase: NA
-
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
NCT06102356 ·Status: COMPLETED
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT04765332 ·Status: COMPLETED
-
Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris
NCT00235625 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
NCT03662685 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients
NCT03807453 ·Status: COMPLETED
-
Oral Psoriasis Treatment Adherence and Intervention Study
NCT02850900 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953 ·Status: COMPLETED
-
Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis
NCT00763555 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis
NCT00236119 ·Status: COMPLETED ·Phase: PHASE2
-
Prednisolone in Early Diffuse Systemic Sclerosis
NCT03708718 ·Status: COMPLETED ·Phase: PHASE2
-
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
NCT00823914 ·Status: COMPLETED
-
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT04099979 ·Status: WITHDRAWN
-
Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries
NCT02668341 ·Status: UNKNOWN
-
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
NCT05144165 ·Status: UNKNOWN
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914 ·Status: COMPLETED
-
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
NCT00606450 ·Status: COMPLETED ·Phase: PHASE2